title: Modulation of serum levels of sRAGE by bromelain in patients with chronic kidney disease: a pilot study.
authors.forename: Bartosz
authors.initials: B
authors.lastname: Foroncewicz
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Mucha
authors.forename: August
authors.initials: A
authors.lastname: Heidland
authors.forename: Michał
authors.initials: M
authors.lastname: Ciszek
authors.forename: Jacek
authors.initials: J
authors.lastname: Imiela
authors.forename: Frank
authors.initials: F
authors.lastname: Helle
authors.forename: Leszek
authors.initials: L
authors.lastname: Pączek
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000818:Animals; D001963:Bromelains / Q000494:pharmacology*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy / Q000379:methods*; D010865:Pilot Projects; D010936:Plant Extracts / Q000494:pharmacology*; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000187:drug effects* / Q000378:metabolism*; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy* / Q000378:metabolism*; D055815:Young Adult
chemical_list: D010936:Plant Extracts; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic; D001963:Bromelains